Professional
Added to YB: 2025-03-21
Pitch date: 2024-12-31
VRTX [bullish]
Vertex Pharmaceuticals Incorporated
+16.4%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally.
Market Cap
$119.5B
Pitch Price
$403.14
Price Target
N/A
Dividend
N/A
EV/EBITDA
21.37
P/E
30.70
EV/Sales
9.10
Sector
Biotechnology
Category
growth
Show full summary:
Parnassus Core Equity Fund New Position: Vertex Pharmaceuticals Incorporated
VRTX (new position): High-quality biotech with strong management. Promising acquisition and advanced diabetes pipeline. Innovative approach and management expected to achieve positive clinical outcomes, strengthening competitive advantage.
Read full article (1 min)